| Identification | Back Directory | [Name]
Cortistatin-29 (human) | [CAS]
1815618-16-6 | [Synonyms]
Cortistatin-29 (human)
Pyr-Glu-Gly-Ala-Pro-Pro-Gln-Gln-Ser-Ala-Arg-Arg-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys-OH | [Molecular Formula]
C149H223N47O42S3 | [MOL File]
1815618-16-6.mol | [Molecular Weight]
3440.89 |
| Chemical Properties | Back Directory | [density ]
1.57±0.1 g/cm3(Predicted) | [form ]
Solid | [color ]
White to off-white | [Sequence]
{Pyr}-Glu-Gly-Ala-Pro-Pro-Gln-Gln-Ser-Ala-Arg-Arg-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge: Cys17-Cys28) |
| Hazard Information | Back Directory | [Uses]
Cortistatin-29 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2]. | [References]
[1] Spier AD, et al. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41. DOI:10.1016/s0165-0173(00)00031-x
[2] Campos-Salinas J, et al. Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders. Pharmaceutics. 2022 Dec 13;14(12):2785. DOI:10.3390/pharmaceutics14122785 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|